Delivery Order SPE2DB20D3103-SPE2DB24FN0K2
- Not listed
- This federal contract award, valued at $2,000.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Feraheme 510 mg/17 ml vials. The contract is a Firm Fixed Price Delivery Order with a performance period extending through April 30, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
- This federal contract award, valued at $25,193.87, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Feraheme 510 mg/17 ml vials, a pharmaceutical product used in medical treatment. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award, valued at $1,580.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Feraheme 510 mg/17 ml vials, a medical product, with a performance period extending through May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $16,135.83, is for the delivery of Feraheme 510 mg/17 ml vials to support military treatment programs and facilities. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential ceiling value of up to $999,999,999 through December 2025. The contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,298.26, is for the delivery of 4566197516 - FERAHEME 510 MG/17 ML VIAL 17ML. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Feraheme 510 mg/17 ml vials. The contract is a firm fixed-price delivery order with a ceiling value of $54,916.16 and a performance period extending to July 7, 2025. The award is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Feraheme, a 510 mg/17 ml vial medication, with a ceiling value of $11,000.22 and a completion date of July 8, 2024. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,424.14 delivery order is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a specialty pharmaceutical product. The contract is a firm fixed price arrangement with a completion date of July 7, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,742.93 Firm Fixed Price Delivery Order contract is for the provision of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Feraheme 510 mg/17 ml vials to the Defense Logistics Agency (DLA). The $4,011.53 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 10, 2022, with an ultimate completion date of August 11, 2022. The contract was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN0K2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,833.38, is for the delivery of Feraheme 510 mg/17 ml vial medical products. It is a firm fixed-price delivery order contract with a period of performance through March 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries. The contract award reviewed does not have a set-aside designation, indicating open competition. As a major supplier of pharmaceutical and medical products to federal agencies, AmerisourceBergen plays a critical role in supporting the healthcare needs of the U.S. military, veterans, and other government healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.8k | 3/14/24 |